Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX25FEQLE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,231
Award facts
- Contract value 100% obligated
- $24,231.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $24,231.30 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on April 21, 2025, with an ultimate completion date of April 22, 2025. This delivery order, which carries no set-aside designation, represents a task order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program. The company will perform work at its Park Ridge, Illinois facility, leveraging its established position as a critical supplier in the federal pharmaceutical supply chain to the Department of Defense.
This delivery order enables the Defense Logistics Agency to procure pharmaceutical products supporting medical supply needs of military health facilities. DMS Pharmaceutical Group's broader IDC contract, valued at $499,999,999 and valid through November 2026, covers an extensive portfolio of pharmaceutical items including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories. The company's consistent success in securing federal pharmaceutical contracts without set-aside designations demonstrates its competitive capability in the government procurement market, where it supplies specialty medications, vaccines, oncology treatments, and other critical pharmaceutical products directly to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DX25FEQLE?
SPE2DX25FEQLE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on April 21, 2025.
How much is contract SPE2DX25FEQLE worth?
The government has obligated $24,231 on SPE2DX25FEQLE.
Is contract SPE2DX25FEQLE an order under another contract?
Yes. SPE2DX25FEQLE is a delivery order under SPE2DX16D9418, an indefinite delivery contract.
Was contract SPE2DX25FEQLE competed?
The extent of competition for SPE2DX25FEQLE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award